Palonosetron versus ondansetron for prevention of chemotherapy-induced nausea and vomiting in paediatric patients with cancer receiving moderately or highly emetogenic chemotherapy: a randomised, phase 3, double-blind, double-dummy, non-inferiority (Q87131674)

From Wikidata

Jump to navigation Jump to search

scientific article published on 19 January 2016

Language	Label	Description	Also known as
English	Palonosetron versus ondansetron for prevention of chemotherapy-induced nausea and vomiting in paediatric patients with cancer receiving moderately or highly emetogenic chemotherapy: a randomised, phase 3, double-blind, double-dummy, non-inferiority	scientific article published on 19 January 2016

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26795844%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

Palonosetron versus ondansetron for prevention of chemotherapy-induced nausea and vomiting in paediatric patients with cancer receiving moderately or highly emetogenic chemotherapy: a randomised, phase 3, double-blind, double-dummy, non-inferiority study (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26795844%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

(3aS)-palonosetron

1 reference

based on heuristic

inferred from title

author name string

Gábor Kovács

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26795844%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

Antonio E Wachtel

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26795844%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

Elena V Basharova

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26795844%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

Tulla Spinelli

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26795844%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

Pierre Nicolas

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26795844%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

Edita Kabickova

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26795844%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

publication date

19 January 2016

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26795844%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

Lancet Oncology Commission

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26795844%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

17

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26795844%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26795844%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

332-344

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26795844%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

On the receiving end. V: Patient perceptions of the side effects of cancer chemotherapy in 1993.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2900520-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Antiemetics in children receiving chemotherapy. MASCC/ESMO guideline update 2009.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2900520-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Emesis as a Critical Problem in Chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2900520-3

7 January 2021

based on heuristic

inferred from DOI database lookup

The missing voice of patients in drug-safety reporting

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2900520-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Incidence of chemotherapy-induced nausea and emesis after modern antiemetics

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2900520-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Quality of life studies in chemotherapy-induced emesis.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2900520-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Impact of 5-HT3 receptor antagonists on chemotherapy-induced nausea and vomiting: a retrospective cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2900520-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy and safety of palonosetron for the prophylaxis of chemotherapy-induced nausea and vomiting (CINV): a systematic review and meta-analysis of randomized controlled trials

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2900520-3

7 January 2021

based on heuristic

inferred from DOI database lookup

The impact of chemotherapy-related nausea on patients' nutritional status, psychological distress and quality of life

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2900520-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Guidelines for antiemetic treatment of chemotherapy-induced nausea and vomiting: past, present, and future recommendations

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2900520-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Guideline update for MASCC and ESMO in the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting: results of the Perugia consensus conference

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2900520-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Guideline for the prevention of acute nausea and vomiting due to antineoplastic medication in pediatric cancer patients.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2900520-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Improved prevention of moderately emetogenic chemotherapy-induced nausea and vomiting with palonosetron, a pharmacologically novel 5-HT3 receptor antagonist: results of a phase III, single-dose trial versus dolasetron

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2900520-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Palonosetron improves prevention of chemotherapy-induced nausea and vomiting following moderately emetogenic chemotherapy: results of a double-blind randomized phase III trial comparing single doses of palonosetron with ondansetron

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2900520-3

7 January 2021

based on heuristic

inferred from DOI database lookup

A Systematic Review and Meta-Analysis of Intravenous Palonosetron in the Prevention of Chemotherapy-Induced Nausea and Vomiting in Adults

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2900520-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Palonosetron for the prevention of chemotherapy-induced nausea and vomiting in patients with cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2900520-3

7 January 2021

based on heuristic

inferred from DOI database lookup

The Antiemetic 5-HT3 Receptor Antagonist Palonosetron Inhibits Substance P-Mediated Responses In Vitro and In Vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2900520-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Pharmacological mechanisms of 5-HT₃ and tachykinin NK₁ receptor antagonism to prevent chemotherapy-induced nausea and vomiting

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2900520-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Palonosetron exhibits unique molecular interactions with the 5-HT3 receptor

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2900520-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Sign on and eLearn

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2900520-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Single-blind study of the effects of intravenous dolasetron mesylate versus ondansetron on electrocardiographic parameters in normal volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2900520-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Dose-ranging evaluation of the serotonin antagonist dolasetron mesylate in patients receiving high-dose cisplatin

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2900520-3

7 January 2021

based on heuristic

inferred from DOI database lookup

The efficacy and safety of palonosetron compared with granisetron in preventing highly emetogenic chemotherapy-induced vomiting in the Chinese cancer patients: a phase II, multicenter, randomized, double-blind, parallel, comparative clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2900520-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Electrocardiographic findings of palonosetron in cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2900520-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Acute effect of palonosetron on electrocardiographic parameters in cancer patients: a prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2900520-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparative analysis of two rates

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2900520-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Regulatory scientific advice on non-inferiority drug trials

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2900520-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Single-dose oral granisetron versus multidose intravenous ondansetron for moderately emetogenic cyclophosphamide-based chemotherapy in pediatric outpatients with acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2900520-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized double-blind comparison of single high-dose ondansetron and multiple standard-dose ondansetron in chemotherapy-naive pediatric oncology patients

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2900520-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Palonosetron hydrochloride is an effective and safe option to prevent chemotherapy-induced nausea and vomiting in children

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2900520-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Palonosetron for the prevention of nausea and vomiting in children with acute lymphoblastic leukemia treated with high dose methotrexate

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2900520-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Aprepitant for the prevention of chemotherapy-induced nausea and vomiting in children: a randomised, double-blind, phase 3 trial

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2900520-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S1470-2045(15)00520-3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26795844%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26795844%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q87131674&oldid=1511432090"